Abstract
In the genetically homogeneous Danish population, 27 HLA-DR3,4 heterozygous patients with insulin-dependent diabetes mellitus (IDDM) and 19 DR3,4 heterozygous controls without family history of IDDM were investigated for HLA-region markers and Gm and Km immunoglobulin allotypes. The aim was to define susceptibility factors for IDDM development other than HLA-DR using a number of techniques: lymphocytotoxicity (HLA-DR and DQ antigens), cellular methods (Dw and DP typing), restriction fragment length polymorphism (DQ alleles), electrophoresis and immunofixation (BF and C4 allotypes), and passive hemagglutination inhibition (Gm and Km immunoglobulin allotypes). The complement allotype C4A3 and the HLA-DQw8 (DQw3.2) antigen were found in all of the patients, whereas this was the case for only 8 of the 19 controls (P=6 x 10−6): five lacked C4A3, five others lacked DQw8, and one of the controls lacked both of these factors. Fourteen of the patients had the complement allotype C4B3 versus three of the controls (P=0.01). Previously reported family studies suggest that these alleles are part of the following haplotype: B15, BFS, C4A3, C4B3, DR4, Dw4, DQw8, and these factors were found together in ten of the patients versus one of the controls (P=0.01). The markers usually associated with DR3 did not show significant differences between IDDM patients and controls, and the non-HLA markers studied showed no significant deviation from what was expected. In addition to the susceptibility factor DQw8, the study suggests the existence of susceptibility genes for IDDM near the complement C4 genes on DR4-carrying haplotypes. Since recent works have shown that the structural gene for the monokine tumor necrosis factor alpha (TNF-α) is located between the HLA-B and C4 loci and that TNF-α might be of importance in IDDM pathogenesis, the hypothesis is put forward that the C4-associated IDDM susceptibility reflects linkage dis-equilibrium between the C4 gene and a gene controlling TNF-α production. The high relative risk for IDDM in HLA-DR3,4 heterozygotes might be explained by the combined action of IDDM-specific susceptibility genes on DR4 haplotypes and DR3-linked susceptibility genes associated with predisposition to autoimmunity.
Similar content being viewed by others
References
Acha-Orbea, H. and McDevitt, H. O.: The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc Natl Acad Sci USA 84: 2435–2439, 1987
Albert, E. D., M. P. Baur, and W. R. Mayr (eds.): Histocompatibility Testing 1984, Springer Verlag, Berlin, Heidelberg, 1984
Alper, C. A., Boenisch, T., and Watson, L.: Genetic polymorphism in human glycine-rich betaglycoprotein. J Exp Med 135: 68–80, 1972
Awdeh, Z. L. and Alper, C. A.: Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 77: 3576–3580, 1980
Bach, F., Rich, S. S., Barbosa, J., and Segall, M.: Insulin-dependent diabetes-associated HLA-D region encoded determinants. Hum Immunol 12: 59–64, 1985
Batchelor, J. R. and Morris, P. J.: HLA and disease. In W. F. Bodmer (ed.): Histocompatibility Testing 1977, pp. 205–210, Munksgaard, Copenhagen, 1978
Bertrams, J. and Baur, M. P.: Insulin-dependent diabetes mellitus. In E. D. Albert, M. P. Baur, and W. R. Mayr (eds.): Histocompatibility Testing 1984, pp. 348–358, Springer Verlag, Berlin, Heidelberg, 1984
Bertrams, J., Hintzen, U., Schlicht, V., and Schoeps, S.: C4: another marker for type I diabetes. Lancet i: 41, 1982
Bertrams, J., Schoeps, L., Baur, M. P., Luboldt, W., and van Logheim, E.: IgG and IgA heavy chain allotypes in type I diabetes. J Immunogenet 10: 305–310, 1983
Blanc, M. and Ducos, J.: Allotypes of Gm and Km in the French provinces. In E. Ohayon and A. Cambon-Thomsen (eds.): Human Population Genetics, Volume 142, pp. 207–226, Edition INSERM, Paris, 1986
Böhme, J., Carlsson, B., Wallin, J., Möller, E., Persson, B., Peterson, P. A., and Rask, L.: Only one DQ-β restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol 137: 941–947, 1986
Bruserud, O., Paulsen, G., Markussen, G., Lundin, K., Thoresen, A. B., and Thorsby, E.: Genomic HLA-DQβ polymorphism associated with insulin-dependent diabetes mellitus. Scand J Immunol 25: 235–243, 1987
Cambon de Mouzon, A., Ohayon, E., Hauptmann, G., Sevin, A., Abbal, M., Sommer, E., Vergnes, H., and Ducos, J.: HLA-A, B, C, DR antigens, Bf, C4 and glycoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 19: 336–379, 1982
Cambon-Thomsen, A., Thomsen, M., Abbal, M., Sommer, E., Calot, M., Arnaud, J., and Ohayon, E.: A DQw1 associated DR antigen: DR-BON, undefined by serology but defined by a homozygous typing cell. Tissue Antigens 27: 256–261, 1986
Charron, D. J., Lotteau, V., and Turmal, P.: Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation. Nature 312: 157–159, 1984
Clanet, M., Cambon-Thomsen, A., Blanc, M., Bert, M., Ruidavets, J. B., Abbal, M., Calot, M., Arnaud, J., Ohayon, E., and Alperovitch, A.: Multiple sclerosis: epidemiology and im munogenetics in a high risk area in southern France. J Genet Hum 34: 202–203, 1986
Contu, L., Deschamps, I., Lestradet, H., Hors, J., Schmid, M., Busson, M., Benajam, A., Marcelli-Barge, A., and Dausset, J.: HLA haplotype study of 53 juvenile insulin-dependent diabetic (IDD) families. Tissue Antigens 20: 123–140, 1982
de Jongh, B. M., Termijtelen, A., Bruining, G. J., de Vries, R. R. P., and van Rood, J. J.: Relation of insulin-dependent diabetes mellitus (IDD) and the HLA-linked SB system. Tissue Antigens 23: 87–93, 1984
de Mouzon, A., Ohayon, E., Ducos, J., and Hauptmann, G.: Bf and C4 markers for insulin-dependent diabetes mellitus in Basques. Lancet ii: 1364, 1979
Dunham, I., Sargent, A. S., Trowsdale, J., and Campbell, A. R.: Molecular mapping of the human major histocompatibility complex by pulsed-field electrophoresis. Proc Natl Acad Sci USA 84: 7237–7241, 1987
Dupont, B. (ed.): Histocompatibility Testing 1987, Springer Verlag, Berlin, Heidelberg, 1988
Festenstein, H., Awad, J., Hitman, G. A., Cutbush, S., Gorves, A. V., Cassell, P., Ollier, W., and Sachs, J. A.: New HLA polymorphisms associated with autoimmnne disease. Nature 322: 64–67, 1986
Field, L. L., Dizier, M.-H., Anderson, C. E., Spence, M. A., and Rotter, J.I.: HLA-dependent Gm effects in insulin-dependent diabetes: evidence from pairs of affected siblings. Am J Hum Genet 39: 640–647, 1986
Hägglöf, B., Holmgren, G., Holmlund, G., Lindblom, B., Olaisen, B., and Teisberg, P.: Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden. Hum Hered 36: 201–212, 1986
Henson, V., Maclaren, N., Riley, W., and Wakeland, E. K.: Polymorphisms of DQ β genes in HLA-DR4 haplotypes from healthy and diabetic individuals. Immunogenetics 25: 152–160, 1987
Irvine, W. J.: Classification of idiopathic diabetes. Lancet i: 638–642, 1977
Mandrup-Poulsen, T., Bendtzen. K., Nerup, J., Dinarello, C. A., Svenson, M., and Nielsen, J. H.: Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29: 63–67, 1986
Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A., Nerup, J.: Human tumor necrosis factor potentiates human interleukin-1 mediated rat pancreatic β-cell cytotoxicity. J Immunol •: 4077–4082, 1987
Michelsen, B. and Lernmark, A.: Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest 79: 1144–1152, 1987
Monos, D. S., Spielman, R. S., Gogolin, K. J., Radka, S. F., Baker, L., Zmiejewski, C. M., and Kamoun, M.: HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ β restriction fragments and DQ β chain variation. Immunogenetics 26: 299–303, 1987
Morling, N., Platz, P., Ryder, L. P., Svejgaard, A., and Thomsen, M.: Data reduction in HLA-D typing with the primed lymphocyte typing (PLT) technique. The normalized median response (NMR). Tissue Antigens 15: 123–136, 1980
Mølvig, J., Back, L., Christensen, P., Manogue, K. R., Vlassara, H., Platz, P., Nielsen, L. S., Svejgaard, A., and Nerup, J.: Endotoxin stimulated human monocyte secretion of interleukin-1, tumor necrosis factor alpha and prostaglandin E2 show stable interindividual differences. Scand J Immunol 27: 705–716, 1988
Nepom, B. S., Palmer, J., King, S. J., Hansen, J. A., Holbeck, S. L., and Nepom, G. T.: Specific Genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med 164: 345–350, 1986
Nerup, J.: Etiology and pathogenesis of insulin-dependent diabetes mellitus: present views and future developments. In J. M. Martin, R. M. Ehrlich, and F. J. Holland (eds.): Etiology and Pathogenesis of Insulin-Dependent Diabetes Mellitus, pp. 275–288, Raven Press, New York, 1981
Nerup, J., Platz, P., Andersen, O. O., Christy, M., Lyngsøe, J., Poulsen, J. E., Ryder, L. P., Nielsen, L. S., Thomsen, M., and Svejgaard, A.: HLA antigens and diabetes mellitus. Lancet ii: 864–866, 1974
Nerup, J., Mandrup-Poulsen, T., and Mølvig, J.: The HLA-IDDM association: implications for etiology and pathogenesis of IDDM. Diabetes Metab Rev 3: 779–802, 1987
Platz, P., Jakobsen, B. K., Morling, N., Ryder, L. P., Thomsen, M., Christy, M., Kromann, H., Benn, J., Nerup, J., Green, A., and Hauge, M.: HLA-D and DR antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21: 108–115, 1981
Raum, D., Alper, C. A., Stein, R., and Gabbay, K. H.: Genetic marker for insulin-dependent diabetes mellitus. Lancet i: 1208–1210, 1979
Rich, S., O'Neill, G., Dalmasso, A. P., Nerl, C., and Barbosa, J.: Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes mellitus. Diabetes 34: 504–509, 1985
Risch, N.: Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 40: 1–14, 1987
Rotter, J. I. and Rimoin, D. L.: Heterogeneity in diabetes mellitus-update 1978: evidence for further genetic heterogeneity within juvenile-onset insulin-dependent diabetes mellitus. Diabetes 27: 599–605, 1978
Singal, D. P. and Blajchman, M. A.: Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22: 429–432, 1973
Spies, T., Morton, C. C., Nedospasov, S. A., Fiers, W., Pious, D., and Strominger, J.: Genes for the tumor necrosis factors a and β are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 83: 8699–8702, 1986
Svejgaard, A.: One versus more than one IDDM-susceptibility gene within the HLA-system. In J. Köbberling and R. Tattersall (eds.): The Genetics of Diabetes Mellitus, pp. 142–144, Academic Press, London, New York, 1982
Svejgaard, A., Platz, P., Ryder, L. P., Nielsen, L. S., Thomsen, M.: HL-A and disease associations — a survey. Transplant Rev 22: 3–43, 1975
Svejgaard, A., Platz, P., and Ryder, L. P.: Joint report: insulin-dependent diabetes mellitus. In P. I. Terasaki (ed.): Histocompatibility Testing 1980, pp. 638–656, Regents of University of California, Los Angeles, 1980
Svejgaard, A., Jakobsen, B. K., Platz, P., Ryder, L. P., Nerup, J., Christy, M., Borch-Johnsen, K., Parving, H.-H., Deckert, T., Molsted-Pedersen, L., Kühl, C., Buschard, K., and Green, A.: HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 28: 237–244, 1986
Thomsen, M., Platz, P., Andersen, O. O., Christy, M., Lyngsoe, J., Nerup, J., Rasmussen, K., Ryder, L. P., Nielsen, L. S., and Svejgaard, A.: MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev 22: 125–147, 1975
Thomsen, M., Ryder, L. P., Morling, N., Platz, P., Jakobsen, B. K., and Svejgaard, A.: Frequency of nine HLA-D antigens in the Danish population. Tissue Antigens 19: 25–39, 1982
Thomson, G.: HLA-DR antigens and susceptibility to insulin-dependent diabetes mellitus. Am J Hum Genet 36: 1309–1317, 1984
Todd, J. A., Bell, J. I., and McDevitt, H. O.: HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 559–604, 1987
Todd, J. A., Bell, J. I., and McDevitt, H. O.: A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus. Trends Gen 4: 129–134, 1988
van Rood, J. J., van Leeuwen, A., and Ploem, J. S.: Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature 262: 795–797, 1976
Whittingham, S., Mackay, I. R., and Mathews, J. D.: HLA-Gm interactions: clinical implications. Clin Immunol Allergy 4: 623–639, 1984
Zerbib, A., Mølvig, J., Thomsen, M., Coppin, H., Cambon-Thomsen, A., Sommer, E., Nerup, J., and de Preval, C.: Restriction fragment length polymorphism of HLA and non HLA genes in Danish DR3/DR4 heterozygous insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of αDX and insulin linked polymorphic loci and new splits of DQw3 haplotypes. Disease Markers, in press, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomsen, M., Mølvig, J., Zerbib, A. et al. The susceptibility to insulin-dependent diabetes mellitus bis associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3, 4 heterozygotes. Immunogenetics 28, 320–327 (1988). https://doi.org/10.1007/BF00364230
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00364230